Genomictree Inc. (228760) — Net Asset Quality Index
Genomictree Inc. (228760) has a Net Asset Quality Index of 95.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩120.76 Billion minus total liabilities of ₩5.45 Billion yields net assets of ₩115.31 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Genomictree Inc.'s assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Genomictree Inc. Net Asset Quality Index Over Time (2020–2025)
This chart shows how Genomictree Inc.'s Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the index stands at 95.5%, representing net assets of ₩115.31 Billion against total assets of ₩120.76 Billion KRW. See Genomictree Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Genomictree Inc. (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Genomictree Inc. from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Genomictree Inc. market cap and net worth.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.5% | ₩115.31 Billion | ₩120.76 Billion | ₩5.45 Billion | ▲ +0.3 pp |
| 2024 | 95.1% | ₩124.32 Billion | ₩130.68 Billion | ₩6.36 Billion | ▲ +1.0 pp |
| 2023 | 94.1% | ₩125.03 Billion | ₩132.84 Billion | ₩7.81 Billion | ▲ +28.4 pp |
| 2022 | 65.7% | ₩107.05 Billion | ₩162.91 Billion | ₩55.86 Billion | ▲ +0.7 pp |
| 2021 | 65.0% | ₩115.10 Billion | ₩177.15 Billion | ₩62.05 Billion | ▼ -15.8 pp |
| 2020 | 80.8% | ₩95.26 Billion | ₩117.90 Billion | ₩22.64 Billion | — |